HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Volume 20, No. 5, May 2016 – Healthcare Systems & Policies in Asia       » Understanding Healthcare Policies in the Philippines: Cancer Care       » Young Innovators under 35       » Healthcare Cost Effectiveness in Singapore       » ASLAN Pharmaceuticals Opens China Office       » A Journey Inside the Human Body       » Treatment Brings New Hope for Patients Suffering From Fatal Lung Disease      
BIOBOARD - JAPAN
VITAL Corporation to distribute Imagine Eyes’ rtx1™ Adaptive Optics Retinal Camera in Japan
Imagine Eyes, the pioneer in cellular-level retinal imaging, and VITAL Corporation, a leading Japanese distributor of advanced medical devices, announced that VITAL will distribute Imagine Eyes’ rtx1™ Adaptive Optics Retinal Camera in Japan. The device has recently gained regulatory approval.

 “VITAL has a proud history of identifying novel medical technologies that benefit doctors and patients alike” said Mr. Masao Ichinoseki, President of VITAL Corporation. “Imagine Eyes’ retinal camera recently received Shonin (NINSHO) approval from the Japanese Ministry of Health, Labor and Welfare. The device will enable Japanese ophthalmologists to visualize their patients’ retinas in unparalleled detail. We hope that this will allow them to enhance the quality of care they provide and help them save vision.”

 “Japan is the world's second largest market for medical devices after the Unites States” said Mr. Tomoki Tateishi, Marketing Director at VITAL Corporation. “Historically, VITAL uses an effective strategy based in part on inviting leading experts in their field to come and present their experience with the cutting-edge medical devices we supply especially in interventional cardiology and cardiovascular surgery. We will use a similar approach as part of marketing the rtx1 Adaptive Optics Retinal Camera in Japan and we expect to see rapid adoption by ophthalmologists across the country. The first event will spotlight the work of both French and Japanese researchers that use the rtx1.”

 “Several leading Japanese researchers embraced the rtx1's cellular-level-retinal-imaging abilities very early on, and we are very thankful to them for their support as it has been instrumental in creating demand in their country” said Mr. Nicolas Chateau, Imagine Eyes’ Cofounder and CEO.

“We look forward to working with VITAL to provide Japanese ophthalmologists with a new tool that will help further sight-saving research today and potentially improve the already impressive healthcare citizens receive in the future.”

Click here for the complete issue.

NEWS CRUNCH  
news Mundipharma's New Betadine® Facility to Meet Regional Healthcare Challenges
news STRATASYS launches World's First Full-ColoUr Multi-material 3D PRINTER - THE J750 - In Singapore
news World Immunisation Week 2016
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
APBN Editorial Calendar 2016
January:
Guest Editorial - Biotechnology In Korea
February:
Guest Editorial - Biomedical Research Governance
March:
Guest Editorial - Life-Saving Opportunities: A Guide to Regenerative Medicine
April:
Leading-Edge ONCOLOGY
May:
Healthcare Systems & Policies in Asia
June:
Medical Devices and Digital Health Technology
July:
Water Technology
August:
Guest Editorial - Antibody Informatics In Japan
September:
Infectious Diseases
October:
Medical Tourism
November:
Biomedical Imaging Technology
December:
Food Technology
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» Editorial Enquiries: biotech_edit@wspc.com
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   Ms PoPo Kwok or Ms Sok Ching Lim/td>
Copyright© 2015 World Scientific Publishing Co Pte Ltd  •  Privacy Policy